WINDOWNCT06477991
The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Clinical complete response rate with negative MRD
Timeframe: 2023/10/30-2026/10/30
Arms and interventions
Drugs: Tireilizumab(PD-1 inhibitor)
Sites
1 site in 1 country
- Yunnan Cancer HospitalKunming, Yunnan, China